Document is current

Article History

First Online: 24 July 2022

Disclosure

: Matthew Goetz and Judy Boughey have a research collaboration with SymBioSis unrelated to this work. Mathew Goetz has also received grant funding paid to Mayo Clinic from Lilly, Pfizer, and Sermonix, and Judy Boughey has received grant funding paid to Mayo Clinic from Lilly. This work was supported in part by the National Institutes of Health Mayo Clinic Breast SPORE grant P50CA116201 (to MPG). Matthew Goetz has received personal fees for continuing medical education (CME) activities from Research to Practice (June 2021), Clinical Education Alliance (February 2021), Medscape (December 2021), and Curio Science Moderator (January 2022); personal fees for serving as a panelist for a panel discussion for Total Health Conferencing (2021); and consulting fees paid to Mayo Clinic from ARC Therapeutics (March 2022), AstraZeneca (January 2021), Biovica (December 2019), Biotheranostics (July 2020), Blueprint Medicines (January 2021), Eagle Pharmaceuticals (June 2020), Lilly (November 2021), Novartis (June 2020), Pfizer (July 2019), Sermonix (July 2020), and Sanofi Genzyme (December 2021). Tanya L. Hoskin and Courtney N. Day have no disclosures to declare.